AIP mutations cause sporadic and familial pituitary adenomas, but establishing the pathogenic role of missense AIP variants with unknown significance is difficult. 1 The AIP interaction partner AHR -a xenobioticactivated transcription factor -regulates transcription of xenobioticmetabolizing enzymes, mediates xenobiotic toxicity, and has been implicated in tumorigenesis. 2,3
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CONCLUSIONS
AIP deficiency or mutated AIP is associated with reduced Ahr transcriptional activity, independently of variation in Ahr gene expression, in GH3 cells. The effect of AIP variants on AHRdependent transcription is a potential measure of mutation pathogenicity. siRNA Aip-KD did not significantly changed Ahr mRNA levels ( Figure 3 ), but caused a significant reduction of Cyp1a1 mRNA levels, in both FICZ and vehicle-treated cells (Figure 4 ). 
DISCUSSION
There is considerable controversy regarding the role of AIP in AHRmediated signaling. Some in vitro studies showed increase in Ahr transcriptional activity upon overexpression of Aip. 4, 5 On the other hand, lack of Aip was also associated with elevated Ahr transcriptional activity in some reports. 6, 7 These differences could be explained by cell type specificity and by different experimental conditions. In our hands, in GH3 cells, Aip-KD is associated with reduced transcriptional activity of Ahr.
In stable Aip-KD GH3 cells, reduced Cyp1a1 expression was rescued by WT-AIP transfection, but not by the pathogenic p.R304* truncation mutant. The p.C238Y and p.R271W pathogenic missense AIP variants did not rescue Cyp1a1 expression, while the likely pathogenic (based on clinical data) p.R304Q and non-pathogenic p.R16H displayed an intermediate rescue ( Figure 5) .
Transfection of the WT-AIP or the p.R304* truncation mutant in Aip shRNA-KD GH3 cells did not significantly changed Ahr mRNA levels ( Figure 6 ). 
